^
No biomarker
Soft Tissue Sarcoma
envafolimab
Sensitive
:
B
Tracon Pharmaceuticals Press Release - 1 week - (New B)
No biomarker
Soft Tissue Sarcoma
olaratumab
Sensitive
:
A1
No biomarker
Soft Tissue Sarcoma
trabectedin
Sensitive
:
A1
No biomarker
Soft Tissue Sarcoma
pazopanib
Sensitive
:
A1
No biomarker
Soft Tissue Sarcoma
tazemetostat
Sensitive
:
A1
No biomarker
Soft Tissue Sarcoma
doxorubicin hydrochloride
Sensitive
:
A1
No biomarker
Soft Tissue Sarcoma
ifosfamide + epirubicin + mesna
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
AIM
Sensitive
:
A2
NTRK3 fusion
Soft Tissue Sarcoma
entrectinib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
GT
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
ifosfamide
Sensitive
:
A2
NTRK1 fusion
Soft Tissue Sarcoma
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Soft Tissue Sarcoma
larotrectinib
Sensitive
:
A2
NTRK2 fusion
Soft Tissue Sarcoma
larotrectinib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
gemcitabine + dacarbazine
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
cediranib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
sunitinib
Sensitive
:
A2
ALK translocation
Soft Tissue Sarcoma
crizotinib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
regorafenib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
ifosfamide + pegylated liposomal doxorubicin
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
temozolomide
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
dacarbazine
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
gemcitabine + vinorelbine tartrate
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
gemcitabine
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
MAID
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
epirubicin
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
Tyrosine kinase inhibitor
Sensitive
:
A2
NTRK1 fusion
Soft Tissue Sarcoma
entrectinib
Sensitive
:
A2
NTRK2 fusion
Soft Tissue Sarcoma
entrectinib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
eribulin mesylate
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
gemcitabine + docetaxel
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
doxorubicin hydrochloride + ifosfamide + mesna
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
AD
Sensitive
:
A2